Keymed China

Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM

View original content:https://www.prnewswire.co.uk/news-releases/keymed-biosciences--the-latest-results-from-the-phase-ia-clinical-study-of-cmg901-was-presented-at-the-2023-asco-gi-cancers-symposium-301724117.html